Cytomegalovirus infection in pediatric haploidentical stem cell transplantation
Preventing CMV infection significantly impacts the post-transplant course, especially in the setting of mismatched donors. This study showed that preventing CMV by preemptive therapy revealed an undetectable rate of 78.85%. Current polymerase chain reaction (PCR)-directed surveillance and prophylaxis have lowered the incidence of CMV disease and persistent DNAemia.
Authors
- Abdulrahman AlSweed (ORCID: https://orcid.org/0000-0003-0551-9322)
- Sami Al-Hajjar (ORCID: https://orcid.org/0000-0003-4664-9748)
- Raghad Alhuthil (ORCID: https://orcid.org/0000-0001-6677-0452)
- Hawazen Saleh Alsaedi (ORCID: https://orcid.org/0000-0002-7478-2514)
- Suliman Aljumaah (ORCID: https://orcid.org/0000-0002-5526-1174)
- Hibah Alruwaisan
Institutions
- King Faisal Specialist Hospital & Research Centre (SA)
Publication Details
- Journal
- Hematology/Oncology and Stem Cell Therapy
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/hemoncstem.hemoncstem-d-24-00044
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00